SCM
LXRX icon

Stevens Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Stevens Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,142
Closed -$154K – 999
2016
Q4 		$154K Buy
+11,142
New +$179K 0.01% 798
2016
Q2 		– Sell
-16,150
Closed -$193K – 1027
2016
Q1 		$193K Buy
16,150
+3,715
+30% +$38.9K 0.01% 772
2015
Q4 		$166K Buy
+12,435
New +$153K 0.01% 823
2015
Q3 		– Sell
-34,048
Closed -$274K – 1118
2015
Q2 		$274K Buy
+34,048
New +$250K 0.01% 777

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return